ADVFN US – Market Content Editor
-
Nasdaq Notches Second Straight Record Close as Dow Slips and S&P 500 Ends Flat
Wall Street finished Tuesday’s session with a split verdict, as continued strength in technology stocks lifted the Nasdaq to another record close while the Dow Jones Industrial Average drifted lower and the S&P 500 ended essentially unchanged. After Monday’s broad rally, investors spent the day weighing falling oil prices and renewed enthusiasm for artificial intelligence…
-
bioAffinity Technologies to Showcase Lung Cancer Test Data at Veterans’ Research Conference
bioAffinity Technologies (NASDAQ:BIAF) will present new clinical findings on its noninvasive lung cancer test, CyPath® Lung, at the 2026 NAVREF Annual Conference, running September 27–30 in Arlington, Virginia. The company is set to unveil two posters focused on the test’s use in veteran and military healthcare settings. The National Association of Veterans’ Research and Education…
-
Peloton Introduces First Foldable Treadmill With Miley Campaign
Peloton (NASDAQ:PTON) has launched the Peloton Tread Flex, its first foldable treadmill, alongside a marketing campaign featuring singer Miley titled “Let Yourself Run.” The product forms part of a wider refresh of Peloton’s treadmill range, which now comprises three models: the Tread Flex, Tread Vision and Tread+ Vision. The advertising campaign has launched in the…
-
Palo Alto Networks Launches AI-Powered Continuous Security Testing Service
Palo Alto Networks (NASDAQ:PANW) has introduced Unit 42 Continuous Frontier AI Defense, a cybersecurity service designed to identify vulnerabilities and provide remediation guidance through continuous AI-powered testing. The service combines AI models from Anthropic and OpenAI within a proprietary multi-model system, allowing different security tasks to be assigned to the model considered most suitable. According…
-
SoFi Shares Rise 3% as Bank Launches Stablecoin Settlement on Mastercard Network
SoFi Technologies (NASDAQ:SOFI) shares gained 3% on Tuesday after the company announced that SoFi Bank had become the first nationally chartered US bank to introduce live stablecoin settlement across Mastercard’s global payments network. The bank is migrating its entire debit and credit card programme to blockchain-based settlement using SoFiUSD, its US dollar-backed stablecoin. According to…
-
Gorilla Technology Secures Multi-Year Taiwan AI Contract Worth Tens of Millions of Dollars
Gorilla Technology Group (NASDAQ:GRRR) has secured a multi-year contract worth tens of millions of dollars to expand artificial intelligence and analytics infrastructure for an existing government customer in Taiwan. The London-headquartered company said the agreement covers intelligence data integration, AI-powered analytics and accelerated computing infrastructure for an unnamed criminal investigation bureau. Gorilla described the customer…
-
Roche Obesity Drug Enicepatide Delivers 15.5% Weight Loss in Phase 2 Diabetes Trial
Roche (USOTC:RHHBY) has reported positive results from a mid-stage clinical trial of its experimental obesity treatment enicepatide, with patients who have type 2 diabetes achieving average weight loss of 15.5% alongside improvements in blood sugar control. The Swiss pharmaceutical company said the once-weekly injectable treatment met both primary endpoints in the study, which evaluated its…
-
Thor Industries Shares Fall 2% as Q4 Earnings Miss Estimates Despite Revenue Beat
Thor Industries (NYSE:THO) shares declined 2.06% in premarket trading on Tuesday after the recreational vehicle manufacturer reported fourth-quarter earnings below analyst expectations, despite revenue exceeding forecasts. The company posted adjusted earnings per share of $0.78 for the quarter ended 31 July 2026, missing the analyst consensus of $0.91 by $0.13. Revenue reached $2.31 billion, ahead…
-
Celldex Shares Rise 8% as Barzolvolimab Meets Primary Endpoints in Two Phase 3 Trials
Celldex Therapeutics (NASDAQ:CLDX) shares gained 8% on Tuesday after the company reported positive topline results from two Phase 3 trials evaluating barzolvolimab in patients with chronic spontaneous urticaria (CSU). Both EMBARQ-CSU1 and EMBARQ-CSU2 met their primary endpoints and all key secondary endpoints, demonstrating statistically significant improvements in disease activity compared with placebo. The trials form…
-
Viking Therapeutics Shares Surge 27% Following VK2735 Weight-Loss Study Results
Viking Therapeutics (NASDAQ:VKTX) shares rose 27% on Tuesday after the company reported positive topline results from a study evaluating maintenance dosing schedules for its investigational obesity treatment VK2735. The San Diego-based biopharmaceutical company said the findings demonstrated the potential for patients to maintain much of their initial weight loss with less frequent injections following a…